MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Vitamin D and Parkinson’s disease

D. Novotnyy (Novosibirsk, Russian Federation)

Meeting: MDS Virtual Congress 2021

Abstract Number: 979

Keywords: Calcium, Non-motor Scales, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: to study the correlation between vitamin D levels (deficiency) and clinical presentations in patients with Parkinson’s disease

Background: previous studies throughout the world have shown that patients with Parkinson’s disease have low serum vitamin D concentrations and the severity of the disease depends on the deficiency of vitamin D

Method: 127 patients with Parkinson’s disease were ranged by gender, age, stage of the disease. We used the following tests and questionnaires: Schwab и England scale, 1969; Hoehn–Yahr scale, 1967;  MDS Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) 2015; Beck Depression Inventory 1966; HADS, Parkinson’s Disease Questionnairy – 39;  non-motor symptoms questionnaire.
Ten biomarkers were examined in serum from these patients: level of 25-OH vitamin D (25-OH vitamin D, 25(OH)D, 25-hydroxycalciferol), blood protein, basic phosphatase, ionized calcium, calcium total, phosphorus, thyroid stimulating hormone, free thyroxine, parathyroid hormone, calcitonin.
The densitometry also was provided.

Results: working patients with Parkinson’s disease have the higher level of serum vitamin D than patients with Parkinson’s disease who don’t work (p=0.024);
the older patients in debut with Parkinson’s disease are the lower level of serum vitamin D is (p=0.047);
the older patients with Parkinson’s disease who came first are the lower level of serum vitamin D is  (p=0.0378);
the lower level of serum vitamin D is the higher stage of Parkinson’s disease according to Hoehn-Yahr scale is (p=0.0246);
the lower level of serum vitamin D is the more severe non-motor symptoms in patients with Parkinson’s disease are (p=0.033);
the lower level of serum vitamin D is the more severe the cognitive impairment is (p=0.007);
the lower level of serum vitamin D is the longer patients with Parkinson’s disease take levodopa (p=0.0092)

Conclusion: this study is illustrated the importance of understanding the correlation between the deficiency of vitamin D and the severity of Parkinson’s disease. In our study special attention is paid to non-motor symptoms.

To cite this abstract in AMA style:

D. Novotnyy. Vitamin D and Parkinson’s disease [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/vitamin-d-and-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/vitamin-d-and-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley